Literature DB >> 11039425

Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.

L Hesse1, B Schroeder, G Heller, P Kroll.   

Abstract

PURPOSE: To quantify the effect of intravitreally injected tissue plasminogen activator (TPA) and an expanding gas on freshly formed subretinal hemorrhage (SRH). PATIENTS AND METHODS: Thirteen patients with acute (1 week or less) SRH due to age-related macular degeneration (ARMD) were treated with an intravitreal injection of 50 microg TPA, and 24 hours later, with an expanding gas. Fundus photographs taken before and 24 hours after each injection were digitized and calibrated. Area, geometric center, and shift of the SRH were measured at each time point using NIH image analysis software. Elevation of the SRH was assessed by echography.
RESULTS: Compared to the preoperative size, SRH enlarged significantly 24 hours after TPA injection (P < 0.001). A significant shift of the geometric center toward the inferior retinal periphery out of the macula was found after gas injection (P < 0.001). Significant horizontal displacement of the SRH was not noted after TPA or gas injection. More elevated subretinal blood clots showed a larger increase in size after TPA injection than flat clots (P < 0.05).
CONCLUSION: Enlargement of SRH in a gravity-dependent manner indicates subretinal liquefaction of the clot after TPA treatment. An intravitreal injection of gas 24 hours later can significantly displace the SRH inferiorly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039425     DOI: 10.1097/00006982-200009000-00011

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  11 in total

1.  Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.

Authors:  Y Oshima; M Ohji; Y Tano
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

2.  Plasminogen activators promote excitotoxicity-induced retinal damage.

Authors:  Raghuveer S Mali; Mei Cheng; Shravan K Chintala
Journal:  FASEB J       Date:  2005-08       Impact factor: 5.191

3.  [Intravitreal injection. Drugs to treat subretinal hemorrhage].

Authors:  L Hesse
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Retinal toxicity of intravitreal tenecteplase in the rabbit.

Authors:  S A Rowley; S Vijayasekaran; P K Yu; I L McAllister; D-Yi Yu
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

5.  Intravitreal tPA Injection and Pneumatic Displacement for Submacular Hemorrhage in a 10-Year-Old Child.

Authors:  Takayuki Tsuyama; Hiroshi Hirose; Tomohiro Hattori
Journal:  Case Rep Ophthalmol Med       Date:  2016-09-18

6.  Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.

Authors:  Mustafa Gok; V Levent Karabaş; Mehmet S Aslan; Özgür Kara; Süleyman Karaman; Fatih Yenihayat
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

7.  Displacement of submacular hemorrhage with intravitreal tissue plasminogen activator following 27 gauge transvitreal fine needle aspiration biopsy for choroidal melanoma.

Authors:  Ramsudha Narala; Zachary Bodnar; Prithvi Mruthyunjaya
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-28

Review 8.  [Management of submacular hemorrhage : What, when, how?]

Authors:  Lars-Olof Hattenbach; Salvatore Grisanti; Nicolas Feltgen; Argyrios Chronopoulos
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

9.  An Innovatory Surgical Technique for Submacular Hemorrhage Displacement by Means of a Bioengineering Perspective.

Authors:  George Pappas; Nectarios Vidakis; Markos Petousis; Vasiliki Kounali; Apostolos Korlos
Journal:  Vision (Basel)       Date:  2021-05-18

10.  Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration.

Authors:  Khaled Helaiwa; Lina R Paez; Peter Szurman; Kai Januschowski
Journal:  Cureus       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.